Y Combinator makes first follow-on investment to synthetic biology start-up

Ginkgo Bioworks raised $45m in an oversubscribed Series B round from three returning investors and new investor Viking Global.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this